Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Beijing Sharing New Medical Technology is a specialized medical device company based in China, focusing on the research, development, and production of interventional cardiology products. The company is a leader in drug-coated balloon (DCB) technology, offering innovative solutions for the treatment of coronary artery disease without the need for permanent metal stents. Its flagship product, the Sharing Paclitaxel-eluting PTCA balloon catheter, has received NMPA approval and is widely utilized in clinical practice across China. By leveraging precision coating technologies and advanced catheter design, Sharing Medical aims to provide minimally invasive therapeutic options for vascular stenosis. The company continues to expand its portfolio into peripheral vascular interventions and other high-end medical consumables.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Beijing Sharing New Medical Technology.